Full Text View
Tabular View
Study Results
Related Studies
A Study of Herceptin (Trastuzumab) in Combination With Whole Brain Radiotherapy in Patients With HER-2 Positive Breast Cancer
This study has been terminated.
( Study was prematurely terminated due to difficulties experienced in recruiting patients in a reasonable timeframe. )
Study NCT01363986   Information provided by Hoffmann-La Roche

First Received on May 31, 2011.   Last Updated on July 23, 2014   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Additional conditions recognized in this trial
More general conditions related to this trial
Interventions listed in this trial
Additional drug interventions recognized in this trial
More general drug interventions related to this trial
Sponsors listed in this trial